Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications
Amedeo Sciarra(University of Lausanne), Massimo Roncalli(Fondazione Humanitas per la Ricerca), Luca Di Tommaso(Humanitas University), Tomoaki Ichikawa(University of Yamanashi Hospital), Masanori Matsuda(University of Yamanashi Hospital), Gaetano Bulfamante(University of Milan), Marco Maggioni(University of Milan), Silvano Bòsari(Ospedale Maggiore), Katsuhiro Sano(University of Yamanashi Hospital), Annarita Destro(Izumi City General Hospital), Matteo Donadon(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Masayuki Nakano(Nihon University), Shintaro Ichikawa(University of Yamanashi), Hideki Fujii(University of Yamanashi), Hiroyuki Morisaka(University of Yamanashi)
Cited by 59
Related Papers
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
|Hepatology|2014|529
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
|Radiology|2011|354
Surgery for cholangiocarcinoma
|Liver International|2019|338
cHCC‐CCA
|Hepatology|2018|333